Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Quasi-experimental designs in practice-based research settings: design and implementation considerations.

Handley MA, Schillinger D, Shiboski S.

J Am Board Fam Med. 2011 Sep-Oct;24(5):589-96. doi: 10.3122/jabfm.2011.05.110067.

2.

Vital signs: Colorectal cancer screening, incidence, and mortality--United States, 2002-2010.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2011 Jul 8;60(26):884-9.

3.

A proposal to speed translation of healthcare research into practice: dramatic change is needed.

Kessler R, Glasgow RE.

Am J Prev Med. 2011 Jun;40(6):637-44. doi: 10.1016/j.amepre.2011.02.023. Review.

PMID:
21565657
4.

A system-based intervention to improve colorectal cancer screening uptake.

Hoffman RM, Steel SR, Yee EF, Massie L, Schrader RM, Moffett ML, Murata GH.

Am J Manag Care. 2011 Jan;17(1):49-55.

5.

A randomized controlled trial of a tailored interactive computer-delivered intervention to promote colorectal cancer screening: sometimes more is just the same.

Vernon SW, Bartholomew LK, McQueen A, Bettencourt JL, Greisinger A, Coan SP, Lairson D, Chan W, Hawley ST, Myers RE.

Ann Behav Med. 2011 Jun;41(3):284-99. doi: 10.1007/s12160-010-9258-5.

6.

How to use an article about quality improvement.

Fan E, Laupacis A, Pronovost PJ, Guyatt GH, Needham DM.

JAMA. 2010 Nov 24;304(20):2279-87. doi: 10.1001/jama.2010.1692.

PMID:
21098772
7.

Systems of support to increase colorectal cancer screening and follow-up rates (SOS): design, challenges, and baseline characteristics of trial participants.

Green BB, Wang CY, Horner K, Catz S, Meenan RT, Vernon SW, Carrell D, Chubak J, Ko C, Laing S, Bogart A.

Contemp Clin Trials. 2010 Nov;31(6):589-603. doi: 10.1016/j.cct.2010.07.012. Erratum in: Contemp Clin Trials. 2012 Sep;33(5):1103.

8.

Vital signs: breast cancer screening among women aged 50-74 years - United States, 2008.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2010 Jul 9;59(26):813-6.

9.

Recruitment for an internet-based diabetes self-management program: scientific and ethical implications.

Glasgow RE, Strycker LA, Kurz D, Faber A, Bell H, Dickman JM, Halterman E, Estabrooks PA, Osuna D.

Ann Behav Med. 2010 Aug;40(1):40-8. doi: 10.1007/s12160-010-9189-1.

PMID:
20411443
10.

Dissemination and implementation research on community-based cancer prevention: a systematic review.

Rabin BA, Glasgow RE, Kerner JF, Klump MP, Brownson RC.

Am J Prev Med. 2010 Apr;38(4):443-56. doi: 10.1016/j.amepre.2009.12.035. Review.

PMID:
20307814
11.

Effectiveness of a patient- and practice-level colorectal cancer screening intervention in health plan members: design and baseline findings of the CHOICE trial.

Lewis C, Pignone M, Schild LA, Scott T, Winquist A, Rimer BK, Glanz K.

Cancer. 2010 Apr 1;116(7):1664-73. doi: 10.1002/cncr.24962.

12.

Looking at research consent forms through a participant-centered lens: the PRISM readability toolkit.

Ridpath JR, Wiese CJ, Greene SM.

Am J Health Promot. 2009 Jul-Aug;23(6):371-5. doi: 10.4278/ajhp.080613-CIT-94.

PMID:
19601476
13.

A new method for estimating race/ethnicity and associated disparities where administrative records lack self-reported race/ethnicity.

Elliott MN, Fremont A, Morrison PA, Pantoja P, Lurie N.

Health Serv Res. 2008 Oct;43(5 Pt 1):1722-36. doi: 10.1111/j.1475-6773.2008.00854.x.

14.

Recruitment in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: the first phase of recruitment at Henry Ford Health System.

Lamerato LE, Marcus PM, Jacobsen G, Johnson CC.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):827-33. doi: 10.1158/1055-9965.EPI-06-0528.

15.

Promoting regular mammography screening I. A systematic assessment of validity in a randomized trial.

del Junco DJ, Vernon SW, Coan SP, Tiro JA, Bastian LA, Savas LS, Perz CA, Lairson DR, Chan W, Warrick C, McQueen A, Rakowski W.

J Natl Cancer Inst. 2008 Mar 5;100(5):333-46. doi: 10.1093/jnci/djn027.

16.

Generalizability of the results of randomized trials.

Weiss NS, Koepsell TD, Psaty BM.

Arch Intern Med. 2008 Jan 28;168(2):133-5. doi: 10.1001/archinternmed.2007.30. No abstract available.

PMID:
18227357
17.

Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.

Ford JG, Howerton MW, Lai GY, Gary TL, Bolen S, Gibbons MC, Tilburt J, Baffi C, Tanpitukpongse TP, Wilson RF, Powe NR, Bass EB.

Cancer. 2008 Jan 15;112(2):228-42. Review.

18.

The HIPAA authorization form and effects on survey response rates, nonresponse bias, and data quality: a randomized community study.

Beebe TJ, Talley NJ, Camilleri M, Jenkins SM, Anderson KJ, Locke GR 3rd.

Med Care. 2007 Oct;45(10):959-65.

PMID:
17890993
19.

Randomisation to protect against selection bias in healthcare trials.

Kunz R, Vist G, Oxman AD.

Cochrane Database Syst Rev. 2007 Apr 18;(2):MR000012. Review. Update in: Cochrane Database Syst Rev. 2011;(4):MR000012.

PMID:
17443633
20.

Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Hewitson P, Glasziou P, Irwig L, Towler B, Watson E.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001216. Review.

PMID:
17253456
Items per page

Supplemental Content

Support Center